1. Home
  2. BNRG vs AFMD Comparison

BNRG vs AFMD Comparison

Compare BNRG & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNRG
  • AFMD
  • Stock Information
  • Founded
  • BNRG 2012
  • AFMD 2000
  • Country
  • BNRG Israel
  • AFMD Germany
  • Employees
  • BNRG N/A
  • AFMD N/A
  • Industry
  • BNRG
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNRG
  • AFMD Health Care
  • Exchange
  • BNRG Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • BNRG 14.7M
  • AFMD 17.0M
  • IPO Year
  • BNRG 2022
  • AFMD 2014
  • Fundamental
  • Price
  • BNRG $1.45
  • AFMD $1.04
  • Analyst Decision
  • BNRG
  • AFMD Strong Buy
  • Analyst Count
  • BNRG 0
  • AFMD 5
  • Target Price
  • BNRG N/A
  • AFMD $13.50
  • AVG Volume (30 Days)
  • BNRG 396.4K
  • AFMD 131.9K
  • Earning Date
  • BNRG 03-03-2025
  • AFMD 03-27-2025
  • Dividend Yield
  • BNRG N/A
  • AFMD N/A
  • EPS Growth
  • BNRG N/A
  • AFMD N/A
  • EPS
  • BNRG N/A
  • AFMD N/A
  • Revenue
  • BNRG $41,000.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • BNRG N/A
  • AFMD N/A
  • Revenue Next Year
  • BNRG N/A
  • AFMD $225.65
  • P/E Ratio
  • BNRG N/A
  • AFMD N/A
  • Revenue Growth
  • BNRG N/A
  • AFMD N/A
  • 52 Week Low
  • BNRG $0.60
  • AFMD $0.92
  • 52 Week High
  • BNRG $4.11
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • BNRG 51.50
  • AFMD 38.98
  • Support Level
  • BNRG $1.02
  • AFMD $0.98
  • Resistance Level
  • BNRG $1.43
  • AFMD $1.09
  • Average True Range (ATR)
  • BNRG 0.18
  • AFMD 0.06
  • MACD
  • BNRG 0.01
  • AFMD 0.03
  • Stochastic Oscillator
  • BNRG 63.24
  • AFMD 64.03

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is an Israel-based company. It is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: